China Universal Asset Management Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.07M | Sell |
|
|||||
|
2025
Q1 | $8.36M | Sell |
|
|||||
|
2024
Q4 | $9.18M | Buy |
|
|||||
|
2024
Q3 | $9.99M | Buy |
|
|||||
|
2024
Q2 | $6.44M | Sell |
|
|||||
|
2024
Q1 | $5.35M | Buy |
|
|||||
|
2023
Q4 | $5.01M | Buy |
|
|||||
|
2023
Q3 | $634K | Sell |
|
|||||
|
2023
Q2 | $2.48M | Buy |
|
|||||
|
2023
Q1 | $642K | Sell |
|
|||||
|
2022
Q4 | $3.23M | Buy |
|
|||||
|
2022
Q3 | $225K | Buy |
|